Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website. We are a privately held clinical-stage biopharmaceutical company. Our mission is to discover and develop novel CNS drugs as ion modulators and neuroprotectors.

Investors

Share Price

Share Price Feed to be added here shortly.

Current Share Price:
14.60

Currency:
CHF

Change:
0.60

Last Closed:
14.00